AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Selective Capture and Identification of Bacteria

Summary
Purdue University researchers have developed a novel technique for selective capture and identification of pathogenic bacteria using immutable ligands. These are pathogen-specific ligands that the disease-causing organism must bind to in order to remain virulent. Examples of immutable ligands include host cell surface molecules that the pathogen must bind to in order to infect its host and nutrient molecules that the microbe must internalize to survive. This method first immobilizes the immutable ligand onto a chip. When the chip is exposed to its matching pathogen, binding occurs. The chip can then be quantitatively evaluated using image processing algorithms, which are not only fast and accurate, but can also be used in a multiplex approach where a sample can be screened for a wide variety of pathogens simultaneously.
Technology Benefits
Rapid multiplex test resultsDetection invulnerable to pathogen mutations
Technology Application
BiotechnologyToxin DetectionMedical/Healthcare
Detailed Technology Description
Philip LowPurdue ChemistryPurdue Medicinal Chemistry and Molecular PharmacologyPurdue Biomedical EngineeringCenter for Drug DiscoveryLow Research Lab
Countries
United States
Application No.
None
*Abstract

*Background
Rapid identification of infectious pathogens is crucial in limiting the spread of contagious diseases. Unfortunately, current tests for most pathogens require hours or days of processing time. Antibody-based detection strategies have shown faster testing times, but become obsolete when the pathogen mutates its antibody binding sites. With the emergence of increasingly virulent strains of common pathogens, there is a need for new strategies with rapid turnaround times and the ability to detect mutated strains.
*IP Issue Date
None
*IP Type
Other Patent
*Stage of Development
Prototype Testing
*Web Links
Purdue Office of Technology CommercializationPurdueInnovation and EntrepreneurshipPhilip LowPurdue ChemistryPurdue Medicinal Chemistry and Molecular PharmacologyPurdue Biomedical EngineeringCenter for Drug DiscoveryLow Research Lab
Country/Region
USA

For more information, please click Here
Mobile Device